Lillian Cheung

Counsel

Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.

pdf

Lillian Cheung is a counsel in O'Melveny's Hong Kong office. Her practice focuses on capital markets transactions. She has experience in initial public offerings, debt offerings, mergers and acquisitions, and various other commercial transactions. In addition, she advises Hong Kong-listed companies on Listing Rules and other regulatory compliance matters.

Languages

  • English
  • Cantonese
  • Mandarin

Admissions

  • Hong Kong

Education

  • University of Hong Kong, P.C. LL.
  • Manchester Metropolitan University, C.P.E.
  • Hong Kong University of Science and Technology, B. Sc. (Economics)

Initial Public Offerings

  • Dexin China Holdings Company Limited (2019.HK) in its US$190 million IPO on the Main Board of the Hong Kong Stock Exchange
  • Hua Medicine (SEHK: 2522) in its US$110 million IPO on the Main Board of the Hong Kong Stock Exchange sponsored by Goldman Sachs and CLSA Limited
  • Yadea Group Holdings Limited (SEHK: 1585) in its US$166 million global offering and IPO on the Main Board of the Hong Kong Stock Exchange
  • China International Capital Corporation, Goldman Sachs, Morgan Stanley, Citi, and China Merchants Securities as underwriters in the US$925 million global offering and listing of the H shares of Red Star Macalline Group Corporation Ltd. (SEHK: 1528) on the Main Board of the Hong Kong Stock Exchange
  • Deutsche Bank and BOCI Asia Limited (SEHK: 1443) as underwriters in the US$60 million global offering and IPO of Fulum Group Holdings Limited on the Main Board of the Hong Kong Stock Exchange
  • Morgan Stanley, CITIC Securities Corporate Finance, ICBC International and other underwriters in the US$130 million global offering and IPO of China VAST Industrial Urban Development Company Limited (SEHK: 6166) on the Main Board of the Hong Kong Stock Exchange
  • Optics Valley Union Holding Company Limited (SEHK: 0798) in its US$107 million global offering and IPO on the Main Board of the Hong Kong Stock Exchange
  • Deutsche Bank as the sole global coordinator in the US$100 million global offering and IPO of Tsui Wah Holdings Limited (SEHK: 1314) on the Main Board of the Hong Kong Stock Exchange
  • Goldman Sachs and Deutsche Bank as underwriters in the US$336 million global offering and IPO of Sunac China Holdings (SEHK: 0445) on the Main Board of the Hong Kong Stock Exchange. This transaction was awarded "Deal of the Year" by China Business Law Journal in 2010
  • Macquarie, HSBC, and Nomura as underwriters in the US$200 million global offering and IPO of Top Spring International Holdings (SEHK: 1918) on the Main Board of the Hong Kong Stock Exchange, the first-ever listing to provide a mixed media offering in Hong Kong at the time
  • Macquarie, CCB International, and China Merchants Securities as underwriters in the US$108 million global offering and IPO of Shifang Holdings (SEHK: 1831) on the Main Board of the Hong Kong Stock Exchange
VIEW MORE